|
Market Closed -
Nasdaq
01:30:00 13/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 33.53 USD | +0.42% |
|
+5.37% | +0.81% |
| 11/08 | Azenta, Inc. Announces Appointment of Erik J. Bello as Chief Accounting Officer, Effective August 31, 2026 | CI |
| 05/08 | Azenta, Inc., Q3 2026 Earnings Call, Aug 05, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AZENTA, INC. | Other Biotechnology & Medical Research | +0.42% | +5.37% | +0.81% | +14.79% | -59.53% | 146.89Cr |  | |  |
- Stock Market
- Stocks
- AZTA Stock
- Charts Azenta, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
